Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterocycle derivatives and their use for the treatment of CNS disorders

Heterocycle derivatives and their use for the treatment of CNS disorders

US Patent 10428030 · Granted Oct 1, 2019

Estimated economic value: $209,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2025
3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the trea2024
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2024
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2023
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2023
3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the trea2022
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2022
Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain con2020
Fluorinated amide derivatives and their uses as therapeutic agents2020
Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain con2019
Fluorinated epoxyketone-based compounds and uses thereof as proteasome inhibitor2016
Use of D-serine derivatives for the treatment of anxiety disorders2013